正在加载公司
Just reported
Q3 2026 results
From Zimmer Biomet's results release of 2026年11月4日; its quarterly report has since been filed.
Revenue
Actual
US$2.06B
+3.1% y/y
-5.2% q/qGuided
—
No guide given
EPS, GAAP
Actual
US$1.00
-14% y/y
-2.9% q/qGuided
—
No guide given
Operating income, GAAP
Actual
US$307.6M
-12% y/y
-5.7% q/qGuided
—
No guide given
Company outlook
Full year 2026
- EPS, adjustedUS$8.50 – US$8.60Raised +0.9%
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes Zimmer Biomet is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The themes it is part of
Highest-graded in Medical Devices
Graded A or B and worth $2B or more: A first, then the largest.
MDTMedtronic plcUS$131.6BA+
SYKStryker Corp.US$117.9BA+
EWEdwards Lifesciences CorporationUS$61.6BA+
GEHCGE Healthcare Technologies Inc.US$37.5BA
GKOSGlaukos CorpUS$14.5BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026年10月21日CBGraded C, now B
MCKMckesson Corporation2026年11月4日BAGraded B, now A
CVSCVS Health Corp2026年11月4日BAGraded B, now A- EWEdwards Lifesciences Corporation2026年11月4日BAGraded B, now A
- GEHCGE Healthcare Technologies Inc.2026年10月28日CAGraded C, now A
怎么赚钱
- Knee replacement products39%
- Hip replacement products26%
- Sports medicine, extremities and trauma products27%
- Technology, bone cement and surgical products9%
各项收入占比是对six months ended June 30, 2026的估算，并非来自已提交报告的数字。
竞争对手
卖什么6
Knee replacement implants
Artificial parts that replace all or part of a damaged knee, including components used in later repair or replacement procedures.
Hip replacement systems
Artificial parts that replace the ball and socket of the hip; some are fixed with bone cement and others are designed to attach directly to bone.
Sports medicine, extremities and trauma devices
Devices used to repair soft-tissue injuries, stabilize broken bones, and treat conditions in the foot, ankle, shoulder, elbow and wrist.
再显示 3 项
ROSA Robot
A surgical robot that helps surgeons position implants during certain knee, hip and shoulder procedures.
ZBEdge
A group of robotic and digital technologies that gathers information before, during and after surgery to help inform patient care.
Bone cement
Cement and related mixing and delivery products used to attach some orthopedic implants to bone.
谁在买6
- Hospitals and ambulatory surgery centers buy products directly; some keep products on consignment for use in scheduled procedures.
- Orthopedic surgeons, neurosurgeons and other specialists use the products and receive product information and technical support from sales representatives.
- Stocking distributors buy products for resale or distribution to healthcare institutions.
再显示 3 项
- Healthcare dealers distribute products and may act as order agents for hospitals.
- Healthcare purchasing organizations and buying groups negotiate purchasing arrangements for member institutions; members are not required to buy Zimmer Biomet products.
- Consignment sales were approximately 85% (2025, high) of net sales.
靠什么支撑，什么会击垮它
业务依赖什么
- 1Manufacturing depends on outside suppliers for raw materials and components, including some items obtained from single sources.
- 2Sales depend on surgeons' familiarity with the products and on sales representatives and distributors providing product information and support.
- 3The company retains title to many consigned products until they are used, so it must hold inventory near the institutions and procedures that need them.
- 4Demand depends in part on hospital and government healthcare budgets, insurance reimbursement, and the number and timing of surgical procedures.
可能出什么问题
- 1If new implants, surgical devices or technologies do not keep pace with competitors or changing medical practice, customers may choose other products or existing products may become obsolete.
- 2Medical device approvals, manufacturing standards and post-market requirements can delay sales or restrict products if the company does not meet regulatory requirements.
- 3Hospital cost controls, government healthcare budgets and lower reimbursement can put pressure on product prices or reduce customer demand.
关于Zimmer Biomet Holdings, Inc.
Zimmer Biomet makes artificial knees and hips, as well as devices used to repair injuries to bones, joints, and surrounding soft tissue. Surgeons use its ROSA robot to help position implants during some operations. Hospitals and surgery centers buy products directly or through distributors and dealers; many products are kept on consignment for use when a procedure is scheduled.
- 总部
- Warsaw, Indiana
- 成立于
- 1927 (predecessor Zimmer Manufacturing Company)
- 员工人数
- approximately 17,000 (December 31, 2025, high)
- 上市于
- NYSE
- 财年结束
- December 31
基于 Zimmer Biomet Holdings, Inc. 自己向美国证券交易委员会（SEC）提交的申报文件。数字如实呈报，每股历史已重述到今天的股数口径。 这是对一门生意的描述——不是投资建议，也不是买卖任何证券的推荐。
